Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts

Natalie C Direkze1, Kairbaan Hodivala-Dilke, Rosemary Jeffery

  • 1Cancer Research United Kingdom, London Research Institute, London, UK. natalie.direkze@cancer.org.uk

Cancer Research
|December 3, 2004
PubMed

Insights

Bone marrow contributes to myofibroblast populations in pancreatic tumors. This systemic response in tumor stroma suggests potential therapeutic targets for cancer therapy.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Tissue Repair

Background:

  • Myofibroblasts are crucial in tissue repair and fibrosis, but their origin remains debated.
  • Fibrocytes are circulating cells that may differentiate into myofibroblasts at injury sites.
  • Previous research identified bone marrow as a myofibroblast source in various organs, exacerbated by injury.

Purpose of the Study:

  • To investigate if bone marrow contributes to myofibroblast and fibroblast populations within pancreatic tumor stroma.
  • To explore the systemic contribution of bone marrow-derived cells to tumor microenvironment development.

Main Methods:

  • Utilized a RIPTag transgenic mouse model that spontaneously develops pancreatic beta-cell tumors (insulinoma).
  • Employed lineage tracing to identify donor-derived cells within the tumor stroma.
  • Quantified the contribution of bone marrow-derived myofibroblasts and fibroblasts to the tumor microenvironment.

Main Results:

  • Approximately 25% of myofibroblasts within pancreatic tumors were derived from the bone marrow donor.
  • Bone marrow-derived myofibroblasts were predominantly localized at the tumor periphery.
  • Demonstrated that tumor stroma development involves a systemic contribution from the bone marrow.

Conclusions:

  • The bone marrow is a significant source of myofibroblasts and fibroblasts contributing to pancreatic tumor stroma.
  • Tumor stroma formation is, in part, a systemic response involving bone marrow-derived cells.
  • These findings suggest potential therapeutic strategies targeting bone marrow-derived cells for pancreatic cancer treatment.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...